© Copyright Nostre Net
According to MRFR analysis, The Cell
Counting Market size is expected to cross USD 14.56 Billion by 2030 at a
CAGR of 7.8% during the forecast period 2022-2030.
Cell counting is important for research and serves as one of
the major steps in the majority of experiments. It is effectively utilized for
maintaining cell cultures. Moreover, another important application of cell
counting can be seen in the diagnosis of chronic diseases like cancer. For
instance, an increase in the number of white blood cells (WBC) may indicate the
possibility of cancerous growth in the body. Thus, cell counting is important
for microbiology, hematology and other medical specialties.
The growth of the global cell counting market is determined
by numerous factors such as increasing R&D expenditure, rising prevalence
of cancer, and product launches. However, the high cost of devices and product
recalls are projected to restrain the growth of the market during the forecast
period.
The Global Cell Counting Market is currently dominated by
several market players. The key players are involved in product launches,
expansion, and strategic collaborations to strengthen their market positions.
Recently in April 2019, the Nexcelom Bioscience LLC launched Cellaca MX
automated cell counter.
Regional Analysis
The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share
owing to the increase in the incidence of cancer and the presence of
well-established pharmaceutical and biotechnology industry. The cell counting
market in the Americas has further been branched into North America and Latin
America, with the North American market divided into the US and Canada.
The European cell counting market has been categorized as
Western Europe and Eastern Europe. The Western European market has further been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The cell counting market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the
presence of a large patient pool and expansion of healthcare facilities, the
market in Asia-Pacific is expected to be the fastest-growing. The cell counting
market in the Middle East & Africa has been divided into the Middle East
and Africa.
Segmentation
The Global Cell
Counting Market Insights has been segmented based on product, application,
and end-user.
The market, based on type, has been divided into consumables
and instruments. The consumable segment is likely to hold maximum
market share in the global cell counting market. This due to the repeated
purchase of the consumable compared with instrument products.
The global cell counting market based
on application has been segregated into research application,
clinical & diagnostic application, and others. The research application
segment is anticipated to hold the largest share in the market due to the
rising funding for stem cell research.
The end-user segments of the market are
pharmaceutical and biotechnology companies, hospitals, research institutes, and
others. The pharmaceutical and biotechnology companies’ segment is expected to
hold the largest share of the market, as these are used cell counting products
in research and development of new drugs and therapies.
Key Players
Some of the Key Players in the Global Cell Counting
Market are Thermo Fisher Scientific (US), Merck KGaA (Germany),
Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Logos Biosystems,
Inc. (South Korea), Olympus Corporation (Japan), Agilent Technologies, Inc.
(US), PerkinElmer, Inc. (US), Sysmex Corporation (Japan), Abbott Laboratories
(US), and others.
The Wall